GO
| HSI1 | 25,668.03 | +137.75 | 259.69B |
| HSCEI1 | 8,531.58 | +32.85 | 62.84B |
| Back Zoom + Zoom - Block Traded | |
|
FOSUN PHARMA (02196.HK) Subsidiary's Drug Registration Application Approved
2026-08-09 20:22:50 FOSUN PHARMA (02196.HK) announced that the drug registration application for Dobutamine Hydrochloride Injection submitted by its controlling subsidiary Shanghai Chaohui has been approved by the National Medical Products Administration. The approved indication is for heart failure caused by decreased myocardial contractility in organic heart disease, including low cardiac output syndrome following open-heart surgery, as short-term supportive therapy. (de/d)~ AASTOCKS Financial News Website: www.aastocks.com This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. | |